Abbott India Limited - Company Snapshot & SWOT Analysis
Abbott India Limited is a public listed company and a subsidiary of Abbott Laboratories USA. Abbott India has headquarters in Mumbai, Maharashtra. The company manufactures pharmaceutical drugs and enjoys strong brand equity multiple therapeutic categories such as Women's Health, Gastroenterology, Neurology, Thyroid, Diabetes, Urology, Pain Management, Vitamins, Anti-Infectives & other therapy areas. Abbott India has a state-of-the-art formulation plant at Verna, Goa designed to produce high quality, high volume formulations. The Company also has in-house development and medical teams to undertake product and clinical development.
The Company posted revenues of INR 23.45 bn by the end of FY 2013-14 registering an annual growth rate of above 12%. By 2018 the revenue for Abbott India Limited increased to INR 23.24 bn, registering an annual growth rate of 11.44%.
Abbott India revenues are expected to grow at a CAGR of 8.7% for the next five years and reach INR 51.96 bn by end of FY 2023.
Scope of the Abbott India Limited - Company Snapshot & SWOT Analysis Report
The Company posted revenues of INR 23.45 bn by the end of FY 2013-14 registering an annual growth rate of above 12%. By 2018 the revenue for Abbott India Limited increased to INR 23.24 bn, registering an annual growth rate of 11.44%.
Abbott India revenues are expected to grow at a CAGR of 8.7% for the next five years and reach INR 51.96 bn by end of FY 2023.
Scope of the Abbott India Limited - Company Snapshot & SWOT Analysis Report
- This report provides detailed information about Abbott India Limited. including value chain analysis, financial performance, business strategy and SWOT analysis.
- The report identifies the growth drivers and inhibitors for the global pharmaceutical market.
- This report provides information about current and future trends for global pharmaceutical market.
1. EXECUTIVE SUMMARY
Scope of the Abbott India Limited - Company Snapshot & SWOT Analysis Report
Research Methodology
2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET
3. COMPANY PROFILE
3.1 Abbott India Limited
3.1.1 Company Profile
3.1.2 Abbott India in Pharma Manufacturing Value Chain
3.1.3 Abbott India: Financial Performance
3.1.4 Abbott India: Business Strategy
3.1.4.1 Product Level Strategy
3.1.5 SWOT Analysis of Abbott India Limited
Strengths
Weaknesses
Opportunities
Threats
3.1.6 Key Customers of Abbott India Limited
4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET
Orphan Drugs
Biologics and Biosimilars
Current Trends
1. INCREASING SEVERITY OF DRUG PRICE CONTROLS
2. GREATER FOCUS ON RARE DISEASES / ORPHAN DRUGS
3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS
4. INCREASING FOCUS ON CELL THERAPY
5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM
6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS
7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY
Notes
Company Information
Scope of the Abbott India Limited - Company Snapshot & SWOT Analysis Report
Research Methodology
2. GROWTH DRIVERS AND INHIBITORS FOR GLOBAL PHARMACEUTICALS MARKET
3. COMPANY PROFILE
3.1 Abbott India Limited
3.1.1 Company Profile
3.1.2 Abbott India in Pharma Manufacturing Value Chain
3.1.3 Abbott India: Financial Performance
3.1.4 Abbott India: Business Strategy
3.1.4.1 Product Level Strategy
3.1.5 SWOT Analysis of Abbott India Limited
Strengths
Weaknesses
Opportunities
Threats
3.1.6 Key Customers of Abbott India Limited
4. CURRENT AND FUTURE TRENDS IN PHARMACEUTICAL MARKET
Orphan Drugs
Biologics and Biosimilars
Current Trends
1. INCREASING SEVERITY OF DRUG PRICE CONTROLS
2. GREATER FOCUS ON RARE DISEASES / ORPHAN DRUGS
3. INCREASING DEVELOPMENT OF NUCLEIC ACIDS AS THERAPEUTICS
4. INCREASING FOCUS ON CELL THERAPY
5. IMPLANTABLES (BIOELECTRONICS) AND ELECTROCEUTICALS ARE EXPECTED TO BECOME MAINSTREAM
6. USE OF 3D PRINTING TO REDUCE COST AND IMPROVE PRODUCTION EFFICIENCY OF BIOLOGICS
7. INCREASING USE OF BIG DATA AND ARTIFICIAL INTELLIGENCE (AI) IN DRUG DISCOVERY
Notes
Company Information
LIST OF EXHIBITS
Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key Information of Abbott India
Exhibit 3. 2 Contact Information of Abbott India
Exhibit 3.3 Abbott India in Pharma Manufacturing Value chain
Exhibit 3.4 Abbott India Limited Revenue 2014-18 (in INR billion)
Exhibit 3.5 Abbott India Growth Rate 2014-2018 (in %)
Exhibit 3.6 Estimated Year wise Abbott India Revenue 2019-2023 (in INR billion)
Exhibit 3.7 Top performing brands of Abbott India 2018
Exhibit 3.8 Top New Products of Abbott India 2018
Exhibit 3.9 SWOT Analysis of Abbott India
Exhibit 2.1 Growth Drivers and Inhibitors for Global Pharmaceuticals Market
Exhibit 3.1 Key Information of Abbott India
Exhibit 3. 2 Contact Information of Abbott India
Exhibit 3.3 Abbott India in Pharma Manufacturing Value chain
Exhibit 3.4 Abbott India Limited Revenue 2014-18 (in INR billion)
Exhibit 3.5 Abbott India Growth Rate 2014-2018 (in %)
Exhibit 3.6 Estimated Year wise Abbott India Revenue 2019-2023 (in INR billion)
Exhibit 3.7 Top performing brands of Abbott India 2018
Exhibit 3.8 Top New Products of Abbott India 2018
Exhibit 3.9 SWOT Analysis of Abbott India
